Location of Repository

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

By P. Schoenfeld, M. Pimentel, L. Chang, A. Lembo, W. D. Chey, J. Yu, C. Paterson, E. Bortey and W. P. Forbes
Publisher: Salix Pharmaceuticals, Inc.
Year: 2014
DOI identifier: 10.1111/apt.12735
OAI identifier: oai:deepblue.lib.umich.edu:2027.42/106831
Journal:

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.